NCT01864915View on ClinicalTrials.gov

Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Bowel CleansingColon Capsule Completion Times
Interventions
DRUG

Prucalopride

Prucalopride 2mg daily starting three days before the colon capsule study (total of 4 doses with the last at 0800hrs on day of colon capsule study)

PROCEDURE

Colon Capsule

Colon capsule procedure performed day prior to colonoscopy, at 0800 hrs on day 4.

Trial Locations (1)

K7L 5V7

Hotel Dieu Hospital, Kingston

All Listed Sponsors
collaborator

Hotel Dieu Hospital

OTHER

collaborator

Janssen Inc.

INDUSTRY

lead

Queen's University

OTHER

NCT01864915 - Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule | Biotech Hunter | Biotech Hunter